N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate

C99H122N26O8 — CID 157482801

IUPACN-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate
SMILESCC(=O)CCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.COCCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.Cc1ccc(-c2nn(C(C)(C)CNC(=O)CCCCCNC(=O)OCc3ccccc3)c3ncnc(N)c23)cc1.Cc1ccc(-c2nn(C(C)(C)CNC(=O)c3cccc(N4CCCCC4)c3)c3ncnc(N)c23)cc1
InChIInChI=1S/C30H37N7O3.C28H33N7O.C21H26N6O2.C20H26N6O2/c1-21-13-15-23(16-14-21)26-25-27(31)34-20-35-28(25)37(36-26)30(2,3)19-33-24(38)12-8-5-9-17-32-29(39)40-18-22-10-6-4-7-11-22;1-19-10-12-20(13-11-19)24-23-25(29)31-18-32-26(23)35(33-24)28(2,3)17-30-27(36)21-8-7-9-22(16-21)34-14-5-4-6-15-34;1-13-5-8-15(9-6-13)18-17-19(22)24-12-25-20(17)27(26-18)21(3,4)11-23-16(29)10-7-14(2)28;1-13-5-7-14(8-6-13)17-16-18(21)23-12-24-19(16)26(25-17)20(2,3)11-22-15(27)9-10-28-4/h4,6-7,10-11,13-16,20H,5,8-9,12,17-19H2,1-3H3,(H,32,39)(H,33,38)(H2,31,34,35);7-13,16,18H,4-6,14-15,17H2,1-3H3,(H,30,36)(H2,29,31,32);5-6,8-9,12H,7,10-11H2,1-4H3,(H,23,29)(H2,22,24,25);5-8,12H,9-11H2,1-4H3,(H,22,27)(H2,21,23,24)
InChIKeyBWIVSVPLCKIJAP-UHFFFAOYSA-N
MW1804.24 g/mol
LogP14.14
Rot. Bonds32

About N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate

N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate (PubChem CID 157482801) has the molecular formula C99H122N26O8 and a molecular weight of 1804.24 g/mol. Its IUPAC name is N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate.

Molecular Properties

Compound NameN-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate
PubChem CID157482801
Molecular FormulaC99H122N26O8
Molecular Weight1804.24 g/mol
Exact Mass1802.99
IUPAC NameN-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate
SMILESCC(=O)CCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.COCCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.Cc1ccc(-c2nn(C(C)(C)CNC(=O)CCCCCNC(=O)OCc3ccccc3)c3ncnc(N)c23)cc1.Cc1ccc(-c2nn(C(C)(C)CNC(=O)c3cccc(N4CCCCC4)c3)c3ncnc(N)c23)cc1
InChIInChI=1S/C30H37N7O3.C28H33N7O.C21H26N6O2.C20H26N6O2/c1-21-13-15-23(16-14-21)26-25-27(31)34-20-35-28(25)37(36-26)30(2,3)19-33-24(38)12-8-5-9-17-32-29(39)40-18-22-10-6-4-7-11-22;1-19-10-12-20(13-11-19)24-23-25(29)31-18-32-26(23)35(33-24)28(2,3)17-30-27(36)21-8-7-9-22(16-21)34-14-5-4-6-15-34;1-13-5-8-15(9-6-13)18-17-19(22)24-12-25-20(17)27(26-18)21(3,4)11-23-16(29)10-7-14(2)28;1-13-5-7-14(8-6-13)17-16-18(21)23-12-24-19(16)26(25-17)20(2,3)11-22-15(27)9-10-28-4/h4,6-7,10-11,13-16,20H,5,8-9,12,17-19H2,1-3H3,(H,32,39)(H,33,38)(H2,31,34,35);7-13,16,18H,4-6,14-15,17H2,1-3H3,(H,30,36)(H2,29,31,32);5-6,8-9,12H,7,10-11H2,1-4H3,(H,23,29)(H2,22,24,25);5-8,12H,9-11H2,1-4H3,(H,22,27)(H2,21,23,24)
InChIKeyBWIVSVPLCKIJAP-UHFFFAOYSA-N
XLogP14.14
TPSA462.75 Ų
H-Bond Donors9
H-Bond Acceptors29
Rotatable Bonds32
Heavy Atoms133
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001804.24
LogP ≤ 514.14
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate?
The IUPAC name of N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate (CID 157482801) is N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate.
What is the SMILES notation for N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate?
The canonical SMILES for N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate is CC(=O)CCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.COCCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.Cc1ccc(-c2nn(C(C)(C)CNC(=O)CCCCCNC(=O)OCc3ccccc3)c3ncnc(N)c23)cc1.Cc1ccc(-c2nn(C(C)(C)CNC(=O)c3cccc(N4CCCCC4)c3)c3ncnc(N)c23)cc1.
What is the InChIKey of N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate?
The InChIKey is BWIVSVPLCKIJAP-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H37N7O3.C28H33N7O.C21H26N6O2.C20H26N6O2/c1-21-13-15-23(16-14-21)26-25-27(31)34-20-35-28(25)37(36-26)30(2,3)19-33-24(38)12-8-5-9-17-32-29(39)40-18-22-10-6-4-7-11-22;1-19-10-12-20(13-11-19)24-23-25(29)31-18-32-26(23)35(33-24)28(2,3)17-30-27(36)21-8-7-9-22(16-21)34-14-5-4-6-15-34;1-13-5-8-15(9-6-13)18-17-19(22)24-12-25-20(17)27(26-18)21(3,4)11-23-16(29)10-7-14(2)28;1-13-5-7-14(8-6-13)17-16-18(21)23-12-24-19(16)26(25-17)20(2,3)11-22-15(27)9-10-28-4/h4,6-7,10-11,13-16,20H,5,8-9,12,17-19H2,1-3H3,(H,32,39)(H,33,38)(H2,31,34,35);7-13,16,18H,4-6,14-15,17H2,1-3H3,(H,30,36)(H2,29,31,32);5-6,8-9,12H,7,10-11H2,1-4H3,(H,23,29)(H2,22,24,25);5-8,12H,9-11H2,1-4H3,(H,22,27)(H2,21,23,24).
What are the key properties of N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate?
N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate has a molecular weight of 1804.24 g/mol, XLogP of 14.14, 32 rotatable bonds, 9 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate is sourced from PubChem (CID 157482801), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).